HK1157204A1 - 表位肽及包含它們的疫苗 - Google Patents

表位肽及包含它們的疫苗

Info

Publication number
HK1157204A1
HK1157204A1 HK11111564.0A HK11111564A HK1157204A1 HK 1157204 A1 HK1157204 A1 HK 1157204A1 HK 11111564 A HK11111564 A HK 11111564A HK 1157204 A1 HK1157204 A1 HK 1157204A1
Authority
HK
Hong Kong
Prior art keywords
hig2
urlc10
same
epitope peptide
vaccines containing
Prior art date
Application number
HK11111564.0A
Other languages
English (en)
Inventor
Takuya Tsunoda
Ryuji Ohsawa
Sachiko Yoshimura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of HK1157204A1 publication Critical patent/HK1157204A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK11111564.0A 2008-08-19 2011-10-26 表位肽及包含它們的疫苗 HK1157204A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19
PCT/JP2009/003897 WO2010021112A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Publications (1)

Publication Number Publication Date
HK1157204A1 true HK1157204A1 (zh) 2012-06-29

Family

ID=41707003

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11111564.0A HK1157204A1 (zh) 2008-08-19 2011-10-26 表位肽及包含它們的疫苗

Country Status (17)

Country Link
US (1) US9119800B2 (zh)
EP (1) EP2328600B9 (zh)
JP (1) JP5633025B2 (zh)
KR (1) KR101713581B1 (zh)
CN (2) CN102186491B (zh)
AU (1) AU2009283763B2 (zh)
BR (1) BRPI0917391A2 (zh)
CA (1) CA2734467C (zh)
DK (1) DK2328600T3 (zh)
ES (1) ES2566011T3 (zh)
HK (1) HK1157204A1 (zh)
IL (1) IL211117A (zh)
MX (2) MX355054B (zh)
RU (1) RU2529373C2 (zh)
SG (2) SG10201610206VA (zh)
TW (2) TWI543767B (zh)
WO (1) WO2010021112A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
JP5998370B2 (ja) * 2010-11-17 2016-09-28 アデュロ バイオテック Ｅｇｆｒｖｉｉｉに対する免疫応答を誘発する方法および組成物
EP2872531A4 (en) 2012-07-10 2016-04-06 Oncotherapy Science Inc LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
RU2700881C2 (ru) * 2014-08-04 2019-09-23 Онкотерапи Сайенс, Инк. Пептид, полученный из urlc10, и содержащая его вакцина
EP3335725B1 (en) 2015-08-10 2024-02-28 Toray Industries, Inc. Pds5a epitopes as immunity inducers
EP3336186A4 (en) 2015-08-12 2019-03-06 OncoTherapy Science, Inc. PEPTIDE DERIVED FROM DEPDC1 AND VACCINE CONTAINING SAME
SG11201909541WA (en) 2017-04-26 2019-11-28 Eureka Therapeutics Inc Chimeric antibody/t-cell receptor constructs and uses thereof
KR20200027512A (ko) 2017-06-20 2020-03-12 엥스띠뛰 퀴리 Suv39h1에 결함이 있는 면역 세포
CN115300609A (zh) * 2021-05-08 2022-11-08 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
CA2381348C (en) 1999-08-05 2009-10-06 Kyogo Itoh Lck-derived peptides activating ctls
WO2001023426A2 (en) 1999-09-30 2001-04-05 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
CA2425569A1 (en) 2000-10-13 2002-04-18 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
EP1660677A2 (en) 2003-08-20 2006-05-31 Oncotherapy Science, Inc. Hypoxia-inducible protein 2 (hig2), a novel therapeutic potential target of renal cell carcinoma (rcc)
US20080286313A1 (en) 2004-06-21 2008-11-20 Kyogo Itoh Peptide Vaccines for the Treatment of Cancers
CN101175862A (zh) 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
WO2006090810A2 (en) 2005-02-25 2006-08-31 Oncotherapy Science, Inc. Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
JPWO2006093337A1 (ja) 2005-03-03 2008-08-07 武田薬品工業株式会社 癌の予防・治療剤
EP1907580A2 (en) 2005-07-28 2008-04-09 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
US20080306243A1 (en) 2005-09-07 2008-12-11 Nec Corporation Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide
JP4840858B2 (ja) * 2006-03-16 2011-12-21 学校法人慶應義塾 癌ワクチン
JP5150849B2 (ja) 2006-06-16 2013-02-27 オンコセラピー・サイエンス株式会社 Ｓｐａｒｃ由来の癌拒絶抗原ペプチド及びこれを含む医薬
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
US20100291091A1 (en) 2007-07-30 2010-11-18 ONCOTHERAPY SCIENCE ,inc. Cancer associated gene ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
CA2734467A1 (en) 2010-02-25
EP2328600B1 (en) 2016-01-27
TW201019952A (en) 2010-06-01
CN104958753A (zh) 2015-10-07
AU2009283763B2 (en) 2014-06-19
BRPI0917391A2 (pt) 2015-12-01
AU2009283763A1 (en) 2010-02-25
MX337756B (es) 2016-03-17
AU2009283763A2 (en) 2011-07-07
IL211117A0 (en) 2011-04-28
SG193806A1 (en) 2013-10-30
IL211117A (en) 2017-03-30
US20110243973A1 (en) 2011-10-06
EP2328600A1 (en) 2011-06-08
KR20110045052A (ko) 2011-05-03
ES2566011T3 (es) 2016-04-08
CA2734467C (en) 2017-10-03
WO2010021112A1 (en) 2010-02-25
US9119800B2 (en) 2015-09-01
TWI543767B (zh) 2016-08-01
CN104958753B (zh) 2018-09-25
KR101713581B1 (ko) 2017-03-08
RU2529373C2 (ru) 2014-09-27
TWI580431B (zh) 2017-05-01
DK2328600T3 (en) 2016-03-29
JP5633025B2 (ja) 2014-12-03
CN102186491A (zh) 2011-09-14
MX2011001883A (es) 2011-03-29
CN102186491B (zh) 2015-06-10
RU2011110376A (ru) 2012-09-27
EP2328600B9 (en) 2016-07-13
TW201500055A (zh) 2015-01-01
EP2328600A4 (en) 2013-03-06
JP2012500184A (ja) 2012-01-05
MX355054B (es) 2018-04-03
SG10201610206VA (en) 2017-01-27

Similar Documents

Publication Publication Date Title
EP2326718A4 (en) INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THEM
HK1157204A1 (zh) 表位肽及包含它們的疫苗
IL209967A0 (en) Cdca1 epitope peptides and vaccines containing the same
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
IL214435A0 (en) Foxm1 peptides and vaccines containing the same
IL229926A (en) 3neil peptides and vaccines containing them
IL232461A0 (en) Melk epitope peptides and vaccines containing them
HK1157397A1 (zh) 表位肽及包含它的疫苗
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
EP2614146A4 (en) TTLL4 PEPTIDES AND VACCINES CONTAINING THEM
ZA201104890B (en) Wdrpuh epitope peptides and vaccines containing the same
IL219927A0 (en) Mybl2 peptides and vaccines containing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230810